BE902783A - Appareil et procede pour l'administration pulsee d'agents favorisant la croissance. - Google Patents
Appareil et procede pour l'administration pulsee d'agents favorisant la croissance.Info
- Publication number
- BE902783A BE902783A BE0/215282A BE215282A BE902783A BE 902783 A BE902783 A BE 902783A BE 0/215282 A BE0/215282 A BE 0/215282A BE 215282 A BE215282 A BE 215282A BE 902783 A BE902783 A BE 902783A
- Authority
- BE
- Belgium
- Prior art keywords
- growth promoting
- analogues
- promoting agents
- growth hormone
- pulsed delivery
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 230000001737 promoting effect Effects 0.000 title 1
- 102000018997 Growth Hormone Human genes 0.000 abstract 3
- 108010051696 Growth Hormone Proteins 0.000 abstract 3
- 239000000122 growth hormone Substances 0.000 abstract 3
- 210000004198 anterior pituitary gland Anatomy 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000037213 diet Effects 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Fodder In General (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Procédé et appareil à programme (18, 21, 23) pour le traitement efficace d'un animal vivant, suivant lequel on administre une dose dynamique de facteur de dégagement de l'hormone de croissance ou de ses analogues ou on administre à titre chronique l'hormone de croissance ou ses analogues en régime subdésensibilisant. Procédé de diagnostic chez l'animal vivant atteint d'une insenibilité de l'hypophyse antérieure à l'égard du facteur de dégagement de l'hormone de croissance ou de ses analogues.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/626,400 US4747825A (en) | 1984-06-29 | 1984-06-29 | Apparatus and methodology for pulsed administration of growth promoting agents |
Publications (1)
Publication Number | Publication Date |
---|---|
BE902783A true BE902783A (fr) | 1985-10-16 |
Family
ID=24510242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE0/215282A BE902783A (fr) | 1984-06-29 | 1985-06-28 | Appareil et procede pour l'administration pulsee d'agents favorisant la croissance. |
Country Status (16)
Country | Link |
---|---|
US (1) | US4747825A (fr) |
EP (1) | EP0190199A4 (fr) |
JP (1) | JPS61502519A (fr) |
AU (1) | AU4605385A (fr) |
BE (1) | BE902783A (fr) |
BR (1) | BR8506785A (fr) |
DK (1) | DK294685A (fr) |
FI (1) | FI852516L (fr) |
IL (1) | IL75671A0 (fr) |
MW (1) | MW686A1 (fr) |
NO (1) | NO852603L (fr) |
OA (1) | OA08214A (fr) |
PT (1) | PT80738B (fr) |
RO (1) | RO95012A (fr) |
WO (1) | WO1986000233A1 (fr) |
ZA (1) | ZA854916B (fr) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5089472A (en) * | 1988-01-26 | 1992-02-18 | Laboratorios Serono S.A. | Use of growth hormone releasing factor for improving mental function |
US5065748A (en) * | 1989-11-14 | 1991-11-19 | University Of South Florida | Method of diagnosing growth hormone disorders employing somatostatin and growth hormone releasing hormone |
US5065747A (en) * | 1989-11-21 | 1991-11-19 | University Of South Florida | Method for improving the accuracy of diagnosis of growth hormone deficiency |
US5428013A (en) * | 1991-01-04 | 1995-06-27 | Mugica; Jesus D. | Differential diagnosis and treatment of the states of growth hormone insufficiency (or deficiency) with an alpha-2-adrenergic agonist and a growth hormone releasing peptide |
US7910624B1 (en) | 1995-03-03 | 2011-03-22 | The Trustees Of Boston University | Compositions for the treatment of blood disorders |
EP0731712A4 (fr) * | 1993-10-29 | 2005-11-09 | Univ Boston | Compositions physiologiquement stables d'acide butyrique, de sels et de derives d'acide butyrique, utilisees comme agents antineoplasiques |
JPH10511095A (ja) * | 1994-12-19 | 1998-10-27 | ベス イスラエル ディーコネス メディカル センター インコーポレイテッド | 副甲状腺ホルモン又はその作動薬の低用量継続投与 |
US6403647B1 (en) | 1996-07-26 | 2002-06-11 | Susan P. Perrine | Pulsed administration of compositions for the treatment of blood disorders |
US5939456A (en) * | 1996-07-26 | 1999-08-17 | Perrine; Susan P. | Pulsed administration of compositions for the treatment of blood disorders |
EP1886677A1 (fr) | 1996-07-26 | 2008-02-13 | Susan P. Perrine | Composition comprenant un agent d'induction et agent antiviral pour le traitement de maladies sanguines, virales et cellulaires |
ES2146530B1 (es) * | 1997-12-26 | 2001-04-16 | Consejo Superior Investigacion | Utilizacion del factor de crecimiento igf-i en la fabricacion de composiciones utiles en el tratamiento de la ataxia cerebelar. |
CA2324426A1 (fr) * | 1998-02-11 | 1999-08-19 | Douglas V. Faller | Compositions et techniques de traitement de la mucoviscidose |
DE60332358D1 (de) * | 2002-09-09 | 2010-06-10 | Hanall Pharmaceutical Co Ltd | Protease-resistente modifizierte interferon alpha polypeptide |
US7998930B2 (en) | 2004-11-04 | 2011-08-16 | Hanall Biopharma Co., Ltd. | Modified growth hormones |
WO2010105112A1 (fr) * | 2009-03-11 | 2010-09-16 | Hemaquest Pharmaceuticals, Inc. | Détection d'acides gras à chaîne courte dans des échantillons biologiques |
WO2011014775A1 (fr) | 2009-07-31 | 2011-02-03 | The Brigham And Women's Hospital, Inc. | Modulation de lexpression de sgk1 dans les cellules th17 pour moduler les réponses immunitaires médiées par th17 |
WO2011038224A1 (fr) | 2009-09-24 | 2011-03-31 | Trustees Of Boston University | Procédés pour le traitement de troubles viraux |
WO2011072086A1 (fr) | 2009-12-08 | 2011-06-16 | Hemaquest Pharmaceuticals, Inc. | Procédés et régimes à faible dose pour traiter des troubles des globules rouges |
US20110245154A1 (en) | 2010-03-11 | 2011-10-06 | Hemaquest Pharmaceuticals, Inc. | Methods and Compositions for Treating Viral or Virally-Induced Conditions |
WO2012106281A2 (fr) | 2011-01-31 | 2012-08-09 | The General Hospital Corporation | Molécules trail multimodales et leurs utilisations en thérapies cellulaires |
US9585930B2 (en) | 2011-03-20 | 2017-03-07 | Trustees Of Boston University | Therapeutic agent for emphysema and COPD |
US9480696B2 (en) | 2011-05-04 | 2016-11-01 | Trustees Of Boston University | Proton-motive force stimulation to potentiate aminoglycoside antibiotics against persistent bacteria |
US20140227293A1 (en) | 2011-06-30 | 2014-08-14 | Trustees Of Boston University | Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1) |
EP2766041B1 (fr) | 2011-10-12 | 2018-12-05 | Children's Medical Center Corporation | Compositions combinatoires et méthodes de traitement d'hémoglobinopathies |
US9243037B2 (en) | 2011-11-10 | 2016-01-26 | Trustees Of Boston College | Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity |
US9173884B2 (en) | 2011-11-30 | 2015-11-03 | Trustees Of Boston College | Inhibitors of phosphodiesterase 11 (PDE11) |
US10513540B2 (en) | 2012-07-31 | 2019-12-24 | The Brigham And Women's Hospital, Inc. | Modulation of the immune response |
WO2014035474A1 (fr) | 2012-08-30 | 2014-03-06 | The General Hospital Corporation | Compositions et méthodes de traitement du cancer |
BR112015008118A2 (pt) | 2012-10-12 | 2017-12-05 | Brigham & Womens Hospital Inc | reforço da resposta imune |
US20150366890A1 (en) | 2013-02-25 | 2015-12-24 | Trustees Of Boston University | Compositions and methods for treating fungal infections |
EP3036226B1 (fr) | 2013-08-22 | 2020-01-08 | The General Hospital Corporation | Inhibiteurs de la 12/15-lipoxygénase- humaine |
EP3038625A4 (fr) | 2013-08-29 | 2017-08-23 | Trustees of Boston University | Produits métaboliques intermédiaires pour potentialiser des antibiotiques aminoglycosides dans des infections bactériennes |
ES2909014T3 (es) | 2013-11-26 | 2022-05-04 | Brigham & Womens Hospital Inc | Composiciones y métodos para modular una respuesta inmunitaria |
WO2015089321A2 (fr) | 2013-12-11 | 2015-06-18 | The General Hospital Corporation | Utilisation de protéines d'hormone anti-mullerienne (amh) pour la contraception et la préservation de la réserve ovarienne |
US20170107300A1 (en) | 2014-03-21 | 2017-04-20 | The Brigham And Women's Hospital, Inc. | Methods and compositions for treatment of immune-related diseases or disorders and/or therapy monitoring |
WO2015164364A2 (fr) | 2014-04-25 | 2015-10-29 | The Brigham And Women's Hospital, Inc. | Procédés de manipulation de l'alpha-fœtoprotéine (afp) |
EP3134733B1 (fr) | 2014-04-25 | 2020-10-14 | The Brigham and Women's Hospital, Inc. | Test et procédé pour traiter des patients ayant des maladies à médiation immunitaire |
WO2016044707A1 (fr) | 2014-09-18 | 2016-03-24 | Cedars-Sinai Medical Center | Compositions et procédés de traitement de la fibrose |
AU2016206682B2 (en) | 2015-01-14 | 2021-11-11 | The Brigham And Women's Hospital, Inc. | Treatment of cancer with anti-LAP monoclonal antibodies |
WO2016172479A1 (fr) | 2015-04-22 | 2016-10-27 | Cedars-Sinai Medical Center | Oligopeptides amers administrés par voie entérique pour le traitement du diabète de type 2 |
WO2016196664A1 (fr) | 2015-06-01 | 2016-12-08 | Cedars-Sinai Medical Center | Procédés et utilisation de composés qui se lient à rela de nf-kb |
CN116712552A (zh) | 2015-06-19 | 2023-09-08 | 波士顿大学托管委员会 | 用于治疗疱疹病毒诱导的病况的方法和组合物 |
MX2018001075A (es) | 2015-07-28 | 2019-04-15 | Vyome Therapeutics Ltd | Agentes terapeuticos y profilacticos antibacterianos. |
WO2017058828A1 (fr) | 2015-09-28 | 2017-04-06 | Children's Hospital Los Angeles | Méthodes de traitement de maladies à médiation par les macrophages pro-inflammatoires positifs à l'erbb4 |
US20190255107A1 (en) | 2015-10-09 | 2019-08-22 | The Brigham And Women's Hospital, Inc. | Modulation of novel immune checkpoint targets |
US20200016202A1 (en) | 2016-10-07 | 2020-01-16 | The Brigham And Women's Hospital, Inc. | Modulation of novel immune checkpoint targets |
EP3752532A1 (fr) | 2018-02-12 | 2020-12-23 | Diabetes-Free, Inc. | Anticorps monoclonaux anti-cd40 humain antagonistes améliorés |
WO2020102454A1 (fr) | 2018-11-13 | 2020-05-22 | Regents Of The University Of Minnesota | Peptides ciblant le cd40 et leurs utilisations |
SG11202113215UA (en) | 2019-05-31 | 2021-12-30 | Viracta Subsidiary Inc | Methods of treating virally associated cancers with histone deacetylase inhibitors |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3498228A (en) * | 1967-05-01 | 1970-03-03 | Charles A Blumle | Portable infusion pump |
US3559644A (en) * | 1967-12-14 | 1971-02-02 | Robert F Shaw | Liquid infusion apparatus |
US3809871A (en) * | 1972-12-01 | 1974-05-07 | Nasa | Programmable physiological infusion |
US4273122A (en) * | 1976-11-12 | 1981-06-16 | Whitney Douglass G | Self contained powered injection system |
US4313439A (en) * | 1980-03-24 | 1982-02-02 | Biotek, Inc. | Automated, spring-powered medicament infusion system |
DE3015777A1 (de) * | 1980-04-24 | 1981-10-29 | Ferring Arzneimittel Gmbh, 2300 Kiel | Vorrichtung zur intermittierenden pulsatorischen applikation von fluessigen arzneimitteln |
US4306553A (en) * | 1980-07-22 | 1981-12-22 | The Regents Of The University Of Minnesota | Method of maintaining the fluidity of hormone solutions for parenteral administration |
US4517181A (en) * | 1982-09-15 | 1985-05-14 | The Salk Institute For Biological Studies | Mammalian PGRF |
US4529595A (en) * | 1983-01-13 | 1985-07-16 | The Salk Institute For Biological Studies | GRF Analogs |
-
1984
- 1984-06-29 US US06/626,400 patent/US4747825A/en not_active Expired - Lifetime
-
1985
- 1985-06-26 FI FI852516A patent/FI852516L/fi not_active Application Discontinuation
- 1985-06-27 WO PCT/US1985/001229 patent/WO1986000233A1/fr not_active Application Discontinuation
- 1985-06-27 JP JP60503052A patent/JPS61502519A/ja active Pending
- 1985-06-27 BR BR8506785A patent/BR8506785A/pt unknown
- 1985-06-27 AU AU46053/85A patent/AU4605385A/en not_active Abandoned
- 1985-06-27 EP EP19850903566 patent/EP0190199A4/fr not_active Withdrawn
- 1985-06-28 ZA ZA854916A patent/ZA854916B/xx unknown
- 1985-06-28 PT PT80738A patent/PT80738B/pt unknown
- 1985-06-28 IL IL75671A patent/IL75671A0/xx unknown
- 1985-06-28 NO NO852603A patent/NO852603L/no unknown
- 1985-06-28 DK DK294685A patent/DK294685A/da not_active Application Discontinuation
- 1985-06-28 BE BE0/215282A patent/BE902783A/fr not_active IP Right Cessation
-
1986
- 1986-01-31 MW MW6/86A patent/MW686A1/xx unknown
- 1986-02-27 RO RO86122377A patent/RO95012A/fr unknown
- 1986-02-28 OA OA58797A patent/OA08214A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO1986000233A1 (fr) | 1986-01-16 |
PT80738B (en) | 1986-12-11 |
EP0190199A1 (fr) | 1986-08-13 |
BR8506785A (pt) | 1986-11-25 |
MW686A1 (en) | 1987-03-11 |
FI852516A0 (fi) | 1985-06-26 |
AU4605385A (en) | 1986-01-24 |
ZA854916B (en) | 1986-02-26 |
FI852516L (fi) | 1985-12-30 |
EP0190199A4 (fr) | 1987-12-01 |
OA08214A (en) | 1987-10-30 |
IL75671A0 (en) | 1985-10-31 |
US4747825A (en) | 1988-05-31 |
JPS61502519A (ja) | 1986-11-06 |
DK294685A (da) | 1985-12-30 |
PT80738A (en) | 1985-07-01 |
DK294685D0 (da) | 1985-06-28 |
RO95012A (fr) | 1988-09-15 |
NO852603L (no) | 1985-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE902783A (fr) | Appareil et procede pour l'administration pulsee d'agents favorisant la croissance. | |
Stern et al. | Pituitary-adrenal responsiveness during lactation in rats | |
Edmonds et al. | Measurement of serum TSH and thyroid hormones in the management of treatment of thyroid carcinoma with radioiodine | |
Rosenberg et al. | Prophylaxis of postoperative leg vine thrombosis by low dose subcutaneous heparin or peroperative calf muscle stimulation: a controlled clinical trial. | |
Burke | The triiodothyronine suppression test | |
Smith et al. | Increasing the effectiveness of gold therapy in rheumatoid arthritis | |
NO933044D0 (no) | Fremgangsmaate for behandling av osteoporose | |
Constas | The effects of adrenaline, noradrenaline, and isoprenaline on parkinsonian tremor | |
DE3880587D1 (de) | Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose. | |
NZ209743A (en) | Use of growth hormone to enhance ruminant mammary development | |
Mazer et al. | Evaluation of the constitutional effects of large doses of estrogenic principle | |
Grund et al. | Hyperthyroxinemia in patients receiving thyroid replacement therapy | |
JACOBS | Observations of neuropathic (Charcot) joints occurring in diabetes mellitus | |
Innerfield et al. | Bradykinin antagonism following oral protease therapy | |
Singer | Latency of pancreatic fluid secretory response to intestinal stimulants in the dog. | |
Burhol et al. | Single subcutaneous doses of histamine and pentagastrin in gastric fistula chickens | |
Lincoln | Physiological mechanisms governing the transfer of milk from mother to young | |
KRUGMAN et al. | TRH test as an index of suppression compared with the thyroid radioiodine uptake in euthyroid goitrous patients treated with thyroxine | |
Griswold et al. | Lymphocyte responses to phytohemagglutinin in rheumatoid arthritis and glomerulonephritis and the effects of immunosuppression | |
Fleischer | Effect of oxytetracycline and chloramphenicol on the exocrine pancreatic function in the rat | |
SUTRO et al. | Basis and treatment of calcification of tendinocapsular tissues, especially the supraspinatus tendon | |
Haggendal et al. | The effect of triiodothyronine treatment on the catecholamine content of the blood during infusion of adrenaline in man | |
SU787995A1 (ru) | Способ дифференцировани т и в лимфоцитов человека | |
Sholz | Utilization of the reticular groove contraction in adult cattle: A therapeutical alternative for the practitioner? | |
Riggs et al. | Effect of calcium infusion on serum calcium levels in hypothyroidism |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: THORNER MICHAEL O. Effective date: 19880630 Owner name: LINKIE DANIEL M Effective date: 19880630 |